Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant Staphylococcus aureus

Methicillin-resistant Staphylococcus aureus (MRSA), commonly called a superbug, is a highly alarming antibiotic-resistant population of Staphylococcus aureus (S. aureus) bacteria. Vancomycin (VAN) was first approved by the FDA in 1988, and it is still regarded as the treatment of choice for MRSA. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanamala, Kushal, Bhise, Ketki, Sanchez, Hiram, Kebriaei, Razieh, Luong, Duy, Sau, Samaresh, Abdelhady, Hosam, Rybak, Michael J., Andes, David, Iyer, Arun K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617750/
https://www.ncbi.nlm.nih.gov/pubmed/34834208
http://dx.doi.org/10.3390/pharmaceutics13111791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617750/
https://www.ncbi.nlm.nih.gov/pubmed/34834208
http://dx.doi.org/10.3390/pharmaceutics13111791

Ejemplares similares